| Year |
Citation |
Score |
| 2017 |
Chao MJ, Gillis T, Atwal RS, Mysore JS, Arjomand J, Harold D, Holmans P, Jones L, Orth M, Myers RH, Kwak S, Wheeler VC, MacDonald ME, Gusella JF, Lee JM. Haplotype-based stratification of Huntington's disease. European Journal of Human Genetics : Ejhg. PMID 28832564 DOI: 10.1038/Ejhg.2017.125 |
0.36 |
|
| 2016 |
Naseri NN, Bonica J, Xu H, Park LC, Arjomand J, Chen Z, Gibson GE. Novel Metabolic Abnormalities in the Tricarboxylic Acid Cycle in Peripheral Cells From Huntington's Disease Patients. Plos One. 11: e0160384. PMID 27611087 DOI: 10.1371/Journal.Pone.0160384 |
0.334 |
|
| 2015 |
Straccia M, Garcia-Diaz Barriga G, Sanders P, Bombau G, Carrere J, Mairal PB, Vinh NN, Yung S, Kelly CM, Svendsen CN, Kemp PJ, Arjomand J, Schoenfeld RC, Alberch J, Allen ND, et al. Quantitative high-throughput gene expression profiling of human striatal development to screen stem cell-derived medium spiny neurons. Molecular Therapy. Methods & Clinical Development. 2: 15030. PMID 26417608 DOI: 10.1038/Mtm.2015.30 |
0.391 |
|
| 2015 |
Naseri NN, Xu H, Bonica J, Vonsattel JP, Cortes EP, Park LC, Arjomand J, Gibson GE. Abnormalities in the tricarboxylic Acid cycle in Huntington disease and in a Huntington disease mouse model. Journal of Neuropathology and Experimental Neurology. 74: 527-37. PMID 25978848 DOI: 10.1097/Nen.0000000000000197 |
0.336 |
|
| 2015 |
Mattis VB, Tom C, Akimov S, Saeedian J, Østergaard ME, Southwell AL, Doty CN, Ornelas L, Sahabian A, Lenaeus L, Mandefro B, Sareen D, Arjomand J, Hayden MR, Ross CA, et al. HD iPSC-derived neural progenitors accumulate in culture and are susceptible to BDNF withdrawal due to glutamate toxicity. Human Molecular Genetics. 24: 3257-71. PMID 25740845 DOI: 10.1093/Hmg/Ddv080 |
0.401 |
|
| 2014 |
Todd D, Gowers I, Dowler SJ, Wall MD, McAllister G, Fischer DF, Dijkstra S, Fratantoni SA, van de Bospoort R, Veenman-Koepke J, Flynn G, Arjomand J, Dominguez C, Munoz-Sanjuan I, Wityak J, et al. A monoclonal antibody TrkB receptor agonist as a potential therapeutic for Huntington's disease. Plos One. 9: e87923. PMID 24503862 DOI: 10.1371/Journal.Pone.0087923 |
0.378 |
|
| 2014 |
Bard J, Wall MD, Lazari O, Arjomand J, Munoz-Sanjuan I. Advances in huntington disease drug discovery: novel approaches to model disease phenotypes. Journal of Biomolecular Screening. 19: 191-204. PMID 24196395 DOI: 10.1177/1087057113510320 |
0.409 |
|
| 2012 |
Mattis V, Svendsen S, Ebert A, Svendsen C, King A, Casale M, Winokur S, Batugedara G, Vawter M, Donovan P, Lock L, Thompson L, Zhu Y, Fossale E, Atwal R, ... ... Arjomand J, et al. A11 Induced pluripotent stem cells for basic and translational research on HD Journal of Neurology, Neurosurgery & Psychiatry. 83: A3.2-A4. DOI: 10.1136/Jnnp-2012-303524.11 |
0.45 |
|
| 2012 |
Mattis VB, Svendsen SP, Ebert A, Svendsen CN, King AR, Casale M, Winokur ST, Batugedara G, Vawter M, Donovan PJ, Lock LF, Thompson LM, Zhu Y, Fossale E, Atwal RS, ... ... Arjomand J, et al. Induced pluripotent stem cells from patients with huntington’s disease show CAG repeat expansion associated phenotypes Cell Stem Cell. 11: 264-278. DOI: 10.1016/J.Stem.2012.04.027 |
0.404 |
|
| 2002 |
Arjomand J, Cole S, Evans CJ. Novel orphanin FQ/nociceptin transcripts are expressed in human immune cells. Journal of Neuroimmunology. 130: 100-8. PMID 12225892 DOI: 10.1016/S0165-5728(02)00217-5 |
0.47 |
|
| 2001 |
Arjomand J, Evans CJ. Differential splicing of transcripts encoding the orphanin FQ/nociceptin precursor. Journal of Neurochemistry. 77: 720-9. PMID 11331401 DOI: 10.1046/J.1471-4159.2001.00219.X |
0.455 |
|
| Show low-probability matches. |